A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer|Colon Cancer|Lung Cancer|Gastric Cancer|Solid Tumors
Interventions: DRUG: Veliparib (ABT-888)|DRUG: Placebo
Sponsor: AbbVie